CBUS · Cibus, Inc. · Webcasts, Transcripts & Audio
$1.13
+0.04 (+3.67%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements.”View the 10-Q filed Nov 12, 2026
Market Cap
$86.60M
Shares
76.64M
Volume · Nov 13
148.9K
Avg daily vol (3M)
109.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Cibus, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Cibus, Inc. (CBUS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-12
Cibus, Inc. (CBUS) Q3 2026 Earnings Call
Revenue
$800,000
▲ 30.1% YoY Diluted EPS
$-0.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-13
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Confident tone
Pipeline of additional crop and ingredient opportunities
Rice trait royalty business and Latin America launch
Platform scalability and three-tier business model
Revenue
$994,000
▲ 6.5% YoY Diluted EPS
$-0.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Confident tone
Rice commercial launch (LATAM and U.S.)
Sustainable ingredients / biofragrance
Pipeline breadth (wheat, canola, other crops)
Revenue
$1.68M
▲ 62.6% YoY Diluted EPS
$-0.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Confident tone
Rice program and herbicide-tolerant traits
Geographic expansion and key markets
Commercialization model and royalty framework
Revenue
$1.06M*
▼ 12.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Cibus, Inc. (CBUS) Q3 2025 Earnings Call Transcript
Confident tone
Rice herbicide tolerance commercialization
Geographic expansion (India/Asia)
Rapid Trait Development System (RTDS)
Revenue
$615,000
▼ 63.1% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Cibus, Inc. (CBUS) Q2 2025 Earnings Call Transcript
Confident tone
Rice herbicide tolerance (HT1, HT3)
Biofragrance / sustainable ingredients revenue
Opportunity pipeline traits (productivity, quality)
Revenue
$933,000
▲ 11.3% YoY Diluted EPS
$-0.61
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Cibus, Inc. (CBUS) Q1 2025 Earnings Call Transcript
Confident tone
Rice commercialization (HT traits)
Disease resistance / sclerotinia (white mold)
RTDS gene editing platform
Revenue
$1.03M
▲ 89.7% YoY Diluted EPS
$-1.34
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Cibus, Inc. (CBUS) Q4 2024 Earnings Call
Revenue
$1.21M*
▲ 9.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript
Confident tone
Trait Machine process and speed
Rice platform (HT1, HT3, stacked traits)
Albaugh / RTDC agreement
Revenue
$1.67M
▲ 250.9% YoY Diluted EPS
$-7.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Cibus, Inc. (CBUS) Q2 2024 Earnings Call Transcript
Confident tone
Disease resistance (Sclerotinia)
Herbicide tolerant traits in rice
Crop platforms expansion (wheat, soybean)
Revenue
$838,000
▲ 325.4% YoY Diluted EPS
$-1.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Cibus, Inc. (CBUS) Q1 2024 Earnings Call Transcript
Confident tone
Rapid Trait Development System (RTDS) platform expansion
HT2 trait potential across crops
Regulatory progress for gene editing globally
Revenue
$545,000
▲ 1197.6% YoY Diluted EPS
$-1.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-08
Cibus, Inc. (CBUS) Q4 2023 Earnings Call Transcript
Confident tone
PSR Canola trait commercialization
Herbicide tolerance rice traits
Customer engagements and royalty potential
Revenue
$1.10M*
▲ 2526.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Cibus, Inc. (CBUS) Q3 2023 Earnings Call Transcript
Revenue
$475,000
▲ 1031% YoY Diluted EPS
$-1.59
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Cibus, Inc. (CBUS) Q2 2023 Earnings Call Transcript
Revenue
$197,000
▲ 380.5% YoY Diluted EPS
$-3.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-11-03
Cibus, Inc. (CBUS) Q3 2022 Earnings Call Transcript
Revenue
$42,000
▼ 99.5% YoY Diluted EPS
$-6.36
Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cibus, Inc. (CBUS) Q2 2022 Earnings Call Transcript
Revenue
$41,000
▼ 99.7% YoY Diluted EPS
$-2.66
Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cibus, Inc. (CBUS) Q1 2022 Earnings Call Transcript
Revenue
$32,000
▼ 99.3% YoY Diluted EPS
$-6.70
Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Cibus, Inc. (CBUS) Q4 2021 Earnings Call
Revenue
$1.94M*
▼ 86% YoY Gross margin
-3.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-05
Cibus, Inc. (CBUS) Q3 2021 Earnings Call
Revenue
$7.76M
▲ 48.1% YoY Diluted EPS
$-10.00
Gross margin
-6.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Cibus, Inc. (CBUS) Q2 2021 Earnings Call
Revenue
$11.88M
▲ 415% YoY Diluted EPS
$-6.50
Gross margin
3.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Cibus, Inc. (CBUS) Q1 2021 Earnings Call
Revenue
$4.40M
▲ 85.2% YoY Gross margin
-53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Cibus, Inc. (CBUS) Q4 2020 Earnings Call
Revenue
$13.93M*
▲ 270% YoY Gross margin
-35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Cibus, Inc. (CBUS) Q3 2020 Earnings Call
Revenue
$5.24M
▲ 76.6% YoY Gross margin
-34.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Cibus, Inc. (CBUS) Q2 2020 Earnings Call
Revenue
$2.31M
▲ 465.4% YoY Gross margin
-130.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cibus, Inc. (CBUS) Q1 2020 Earnings Call
Revenue
$2.38M
▲ 1414% YoY Gross margin
-63.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Cibus, Inc. (CBUS) Q4 2019 Earnings Call
Revenue
$3.76M
▲ 188100% YoY Gross margin
-43.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 webcasts
Key facts
CIK
1705843
CUSIP
17166A101
13F (30d)
53 filings
45 filers
Visit website
Investor relations